BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12659752)

  • 1. Potassium channel activators based on the benzopyran substructure: synthesis and activity of the C-8 substituent.
    Thompson R; Doggrell S; Hoberg JO
    Bioorg Med Chem; 2003 Apr; 11(8):1663-8. PubMed ID: 12659752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New R/S-3,4-dihydro-2,2-dimethyl-2H-1-benzopyrans as K(ATP) channel openers: modulation of the 4-position.
    Florence X; Sebille S; Tullio Pd; Lebrun P; Pirotte B
    Bioorg Med Chem; 2009 Nov; 17(22):7723-31. PubMed ID: 19822435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and pharmacological evaluation of R/S-3,4-dihydro-2,2-dimethyl- 6-halo-4-(phenylaminocarbonylamino)-2H-1-benzopyrans: toward tissue-selective pancreatic beta-cell KATP channel openers structurally related to (+/-)-cromakalim.
    Sebille S; Gall D; de Tullio P; Florence X; Lebrun P; Pirotte B
    J Med Chem; 2006 Jul; 49(15):4690-7. PubMed ID: 16854075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New R/S-3,4-dihydro-2,2-dimethyl-6-halo-4-(phenylaminothiocarbonylamino)-2H-1-benzopyrans structurally related to (+/-)-cromakalim as tissue-selective pancreatic beta-cell K(ATP) channel openers.
    Sebille S; de Tullio P; Florence X; Becker B; Antoine MH; Michaux C; Wouters J; Pirotte B; Lebrun P
    Bioorg Med Chem; 2008 May; 16(10):5704-19. PubMed ID: 18406154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the vascular relaxant effects of ATP-dependent K+ channel openers on aorta and pulmonary artery isolated from spontaneously hypertensive and Wistar-Kyoto rats.
    Kwan YW; To KW; Lau WM; Tsang SH
    Eur J Pharmacol; 1999 Jan; 365(2-3):241-51. PubMed ID: 9988108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The synthesis and biological evaluation of a range of novel functionalized benzopyrans as potential potassium channel activators.
    Tyrrell E; Tesfa KH; Greenwood I; Mann A
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1237-40. PubMed ID: 18191566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of the 6-position of benzopyran derivatives and inhibitory effects on the insulin releasing process.
    Florence X; Dilly S; de Tullio P; Pirotte B; Lebrun P
    Bioorg Med Chem; 2011 Jul; 19(13):3919-28. PubMed ID: 21664825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological activity of spirocyclic benzopyran imidazolone potassium channel openers.
    Gadwood RC; Kamdar BV; Dubray LA; Wolfe ML; Smith MP; Watt W; Mizsak SA; Groppi VE
    J Med Chem; 1993 May; 36(10):1480-7. PubMed ID: 8496916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and activity on rat aorta rings and rat pancreatic beta-cells of ring-opened analogues of benzopyran-type potassium channel activators.
    Khelili S; Florence X; Bouhadja M; Abdelaziz S; Mechouch N; Mohamed Y; de Tullio P; Lebrun P; Pirotte B
    Bioorg Med Chem; 2008 Jun; 16(11):6124-30. PubMed ID: 18479927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potassium channel-opening and vasorelaxant profiles of a novel compound YM099 in rat isolated portal vein and rabbit isolated aorta.
    Uchida W; Hirano Y; Shirai Y; Taguchi T; Masuda N; Shibasaki K; Hirano S; Matsumoto Y; Tsuzuki R; Yanagisawa I
    Arch Int Pharmacodyn Ther; 1994; 327(3):330-43. PubMed ID: 7848015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antihypertensive activity of 4-(diazabicyclo[4.1.0]-heptenyloxy)benzopyran derivatives and their analogues.
    Horino H; Mimura T; Kagechika K; Ohta M; Kubo H; Kitagawa M
    Chem Pharm Bull (Tokyo); 1998 Apr; 46(4):602-9. PubMed ID: 9579035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of endothelin-1 on the vasorelaxant properties of benzopyran and non-benzopyran potassium channel openers.
    Lawson K; Barras M; Zazzi-Sudriez E; Martin DJ; Armstrong JM; Hicks PE
    Br J Pharmacol; 1992 Sep; 107(1):58-65. PubMed ID: 1422579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of the alkylsulfonylamino substituent located at the 6-position of 2,2-dimethylchromans structurally related to cromakalim: from potassium channel openers to calcium entry blockers?
    Florence X; Desvaux V; Goffin E; de Tullio P; Pirotte B; Lebrun P
    Eur J Med Chem; 2014 Jun; 80():36-46. PubMed ID: 24763361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The individual enantiomers of cis-cromakalim possess K+ channel opening activity.
    Quast U; Villhauer EB
    Eur J Pharmacol; 1993 Apr; 245(2):165-71. PubMed ID: 8491256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 6-Substituted benzopyrans as potassium channel activators: synthesis, vasodilator properties, and multivariate analysis.
    Mannhold R; Cruciani G; Weber H; Lemoine H; Derix A; Weichel C; Clementi M
    J Med Chem; 1999 Mar; 42(6):981-91. PubMed ID: 10090781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relaxant activity in rat aorta and trachea, conversion to a muscarinic receptor antagonist and structure-activity relationships of new K(ATP) activating 6-varied benzopyrans.
    Lemoine H; Weber H; Derix A; Uhrig U; Höltje HD; Mannhold R
    Eur J Pharmacol; 1999 Jul; 378(1):85-97. PubMed ID: 10478568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATP-sensitive potassium-channel-opening activity of CL-065, a 3-[(substituted-carbonyl)amino]-2H-1-benzopyran, in the rat.
    Chen MJ; Lee YM; Sheu JR; Hu CT; Yen MH
    J Pharm Pharmacol; 1998 Jan; 50(1):83-90. PubMed ID: 9504439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo comparison of two K+ channel openers, diazoxide and cromakalim, and their inhibition by glibenclamide.
    Quast U; Cook NS
    J Pharmacol Exp Ther; 1989 Jul; 250(1):261-71. PubMed ID: 2501478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and antihypertensive activity of substituted trans-4-amino-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-3-ols.
    Evans JM; Fake CS; Hamilton TC; Poyser RH; Watts EA
    J Med Chem; 1983 Nov; 26(11):1582-9. PubMed ID: 6631915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardioselective antiischemic ATP-sensitive potassium channel openers. 2. Structure-activity studies on benzopyranylcyanoguanidines: modification of the benzopyran ring.
    Atwal KS; Grover GJ; Ferrara FN; Ahmed SZ; Sleph PG; Dzwonczyk S; Normandin DE
    J Med Chem; 1995 May; 38(11):1966-73. PubMed ID: 7783128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.